68 Ga-Trivehexin PET/CT Enhances Detection of Small Primary Lesions Than 18 F-FDG PET/CT in Breast Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40644590.
- Also identified by DOI 10.1097/RLU.0000000000006031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared 68 Ga-Trivehexin PET/CT imaging with 18 F-FDG in a 49-year-old woman diagnosed with breast cancer. While both imaging modalities detected a soft tissue mass in the central left breast, 68 Ga-Trivehexin PET/CT identified not only the large lesion but also 3 additional tiny foci that were undetected by 18 F-FDG PET/CT. Our report suggested that 68 Ga-Trivehexin PET/CT might offer superior detection efficacy for breast cancer compared with 18 F-FDG PET/CT, highlighting its potential as an alternative imaging agent.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Fluorodeoxyglucose F18
- Breast Neoplasms